Trial site
Laane-Tallinna Keskhaigla AS
- 10running trials
- 8closed trials
The trials here
What the 18 trials at this site are about, from their registry records.
- Conditions
- Ulcerative colitis6 trials
- Bladder cancer3 trials
- Crohn's disease3 trials
- Multiple sclerosis2 trials
- Stroke2 trials
- Atrial fibrillation1 trial
- IgA nephropathy1 trial
- Phase
- Phase 312 trials
- Phase 25 trials
- Phase 41 trial
- Status
- Completed8 trials
- Active, not recruiting7 trials
- Recruiting3 trials
- Lead sponsor
- AbbVie4 trials
- Janssen Research & Development, LLC3 trials
- Morphic Therapeutic, Inc. (A Wholly Owned Subsidiary of Eli Lilly and Company)2 trials
- UroGen Pharma Ltd.2 trials
- Bayer AG1 trial
- and 6 more
Running trials
Recruiting
Active, not recruiting
Recruiting
A Phase 2 Study to Evaluate MORF-057 in Adults With Moderately to Severely Active Crohn's Disease
Active, not recruiting
Active, not recruiting
Recruiting
Active, not recruiting
An Extension Study for Treatment of Moderately to Severely Active Ulcerative Colitis
Active, not recruiting
Active, not recruiting
A Study of the Efficacy and Safety of Risankizumab in Participants With Crohn's Disease
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Bladder cancer1 recruiting
- Crohn's disease1 recruiting
Closed trials
Completed
Active, not recruiting
Active, not recruiting
Completed
Completed
A Study to Evaluate MORF-057 in Adults With Moderately to Severely Active UC
Active, not recruiting
Active, not recruiting
Completed
A Study of the Effect and Safety of Sparsentan in the Treatment of Patients With IgA Nephropathy
Site data: EU CTIS (euclinicaltrials.eu)Updated 17 Nov 2026